This program is designed for regulated healthcare organizations operating across the United States. Program eligibility, structure, and timelines vary based on organizational type, applicable regulatory requirements, and operational context.
Program eligibility is determined through a structured review process. All arrangements are structured to comply with applicable federal and state laws. Prospective clients are advised to consult qualified healthcare legal counsel prior to entering any arrangement.
Acute care and multi-site health systems evaluating diagnostic service line expansion or outreach laboratory development. Our hospital-based implementation path addresses the complexities of system-scale regulatory requirements, existing infrastructure integration, and multi-site operational coordination.
Implementation Path A — Hospital-Based IntegrationHospital programs are designed for scalable infrastructure that can grow alongside evolving service line demands, including outreach program development that extends laboratory access to affiliated or community-based providers.
Hospital laboratory programs require alignment with CMS Conditions of Participation, CLIA requirements, and applicable Stark Law exceptions for hospital-based arrangements. Outreach programs introduce additional compliance considerations across affiliated sites.
Hospital engagements are typically led by CFOs, COOs, VP of Clinical Operations, or Chief Medical Officers evaluating diagnostic service line expansion. Capital planning, IRB considerations, and system governance requirements are addressed as part of the program design phase.
FQHCs operate under a distinct prospective payment system (PPS) reimbursement methodology. Laboratory program design must account for PPS implications, HRSA program requirements, and applicable Medicaid and Medicare policies. All program structures for FQHCs are designed to align with federal guidance specific to this provider type.
Laboratory programs in FQHC settings are designed to improve diagnostic access for the communities served, reduce reliance on external reference labs, and support care continuity within the health center setting.
Important: FQHC participation is subject to specific reimbursement methodologies and federal program requirements. Program design must align with PPS and applicable HRSA guidance. Consultation with qualified healthcare legal counsel and health center compliance staff is required prior to implementation.
FQHCs operate under distinct federal regulatory and reimbursement structures. Laboratory programs for health centers are designed with PPS reimbursement, HRSA requirements, and community health mission alignment as foundational design principles.
Discuss FQHC program eligibility →Single and multi-specialty physician organizations evaluating in-office or near-site laboratory capabilities in compliance with applicable federal exceptions. In-office testing can reduce patient referral friction and support same-day clinical decision-making.
Implementation Path B — Physician Practice IntegrationPhysician group programs are configured for in-office or near-site diagnostic testing, optimized for the volume and clinical mix of the practice. Configurations range from point-of-care testing to full in-office laboratory buildouts depending on patient volume and specialty.
Physician practice laboratory programs must qualify under an applicable exception to the Stark Law, most commonly the in-office ancillary services (IOAS) exception. This requires that specific structural, supervisory, and billing requirements be met. Legal counsel review is not optional for this provider type.
Private equity-backed physician practice organizations require additional attention to ownership structure, referral arrangements, and compensation model design to ensure compliance with the Stark Law and Anti-Kickback Statute. These structures require thorough legal and compliance review prior to any laboratory arrangement.
Urgent care laboratory programs are designed for rapid turnaround—matching the pace of high-volume ambulatory encounters. Testing capabilities are integrated directly into the clinical visit workflow to support same-visit clinical decision-making.
Urgent care networks operating across multiple locations benefit from standardized testing protocols, centralized laboratory management, and consistent billing compliance frameworks across all sites. Network-level programs are designed with scalability and operational consistency as core objectives.
Urgent care payer mix typically includes a combination of commercial insurance, Medicare, Medicaid, and self-pay patients. Reimbursement modeling and billing compliance are designed to account for the specific payer composition and contractual arrangements of each urgent care organization.
High-volume ambulatory settings requiring rapid turnaround diagnostic capabilities integrated directly into the clinical encounter workflow. Testing is designed to support same-visit decision-making without disrupting operational throughput.
Implementation Path B — Practice IntegrationBehavioral health organizations requiring toxicology screening, medication monitoring, and confirmatory testing capabilities within the care setting. Laboratory programs are designed around the specific diagnostic needs of behavioral health patient populations.
Request a behavioral health feasibility review →Behavioral health laboratory programs center on toxicology screening, confirmatory drug testing, and medication adherence monitoring. Test menus are built around documented clinical need and patient population characteristics specific to behavioral health practice.
Toxicology testing in behavioral health settings is an area of heightened payer and regulatory scrutiny. Medical necessity documentation, appropriate test frequency, and accurate coding are essential to billing compliance and audit readiness. These requirements are integrated into program design from day one.
Toxicology laboratory arrangements in behavioral health settings have been subject to significant enforcement activity by OIG, DOJ, and commercial payers. All program structures are designed to comply with applicable guidance and are subject to mandatory legal counsel review prior to implementation.
Specialty practice laboratory programs are built around the specific diagnostic testing requirements tied to each clinical specialty. Test menus are designed based on documented clinical need and patient population characteristics—not revenue optimization.
Pain management laboratory programs—particularly those involving toxicology and medication compliance testing—operate in an area of significant regulatory and payer scrutiny. Medical necessity documentation, appropriate test frequency, and transparent billing are essential and non-negotiable components of any pain management laboratory arrangement.
Specialty practices evaluating physician-owned laboratory arrangements require careful Stark Law exception analysis, Anti-Kickback Statute review, and assessment of applicable state self-referral laws. All ownership structures are developed in coordination with qualified healthcare legal counsel.
Specialty practices including pain management, oncology, rheumatology, and other clinical disciplines with specific diagnostic testing requirements tied to patient population needs and treatment protocols.
Discuss specialty lab eligibility →All submissions are strictly confidential. We use your answers to determine program eligibility and prepare a personalized response. Takes approximately 5–7 minutes.